Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

Next In Aseanplus News

Hundreds of flights cancelled amid thick smog in India
How China pulled off a critical mineral production tech revolution in just 10 months
India charges Pakistan-based militant groups, six men over Kashmir tourist attack
Valiant Harimau Muda fall to hosts Thailand in SEA Games Under-23 semi-finals
China son nearly dies after sleeping on late mum’s bed in local tradition to help departed souls
Cricket-Stokes issues Ashes rallying cry for England players
Malaysia sets RM100bil franchise sales target by 2030, says Zahid
Asean News Headlines at 10 pm on Monday (Dec 15, 2025)
China strongly dissatisfied with criticism over court verdict on�Jimmy Lai
SEA Games 2025: Where are the fans? Empty seats a bummer at the events in Thailand

Others Also Read